JITC is proud to announce the first publications in a new series, “Liquid Biopsies Coming of Age: Biology, Emerging Technologies, and Clinical Translation.” Authored by leading voices in cancer biology, technology development, and immuno-oncology, this JITC series features authoritative review articles on liquid biopsy- and ctDNA-related uses in immuno-oncology, with accompanying clinically-focused viewpoint letters from expert physicians.
Edited by Valsamo Anagnostou, MD, PhD, and Mark D. Stewart, PhD, “Liquid Biopsies Coming of Age: Biology, Emerging Technologies, and Clinical Translation” aims to serve as a valuable resource to support continued research and validation of the use of liquid biopsies to deliver the earliest, best clinical care with precision.
Check the collection throughout 2023 for new publications.